PharmaResources (Shanghai) Co. Ltd. A (301230) — Financial Flexibility Index
PharmaResources (Shanghai) Co. Ltd. A (301230) has a Financial Flexibility Index of 0.58x as of December 2025. Free cash flow of CN¥178.83 Million (operating CF CN¥135.51 Million minus capex CN¥43.32 Million) represents 1% of total liabilities (CN¥309.87 Million). Check PharmaResources (Shanghai) Co. Ltd. A liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PharmaResources (Shanghai) Co. Ltd. A Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. See PharmaResources (Shanghai) Co. Ltd. A short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Year-by-year free cash flow to debt coverage for PharmaResources (Shanghai) Co. Ltd. A. For the full company profile including market capitalisation, see market value of PharmaResources (Shanghai) Co. Ltd. A.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | CN¥178.83 Million | CN¥135.51 Million | CN¥309.87 Million | ▼ -13.9% |
| 2024 | 0.67x | CN¥190.27 Million | CN¥80.86 Million | CN¥283.73 Million | ▼ -7.9% |
| 2023 | 0.73x | CN¥269.13 Million | CN¥20.86 Million | CN¥369.62 Million | ▼ -38.6% |
| 2022 | 1.19x | CN¥223.26 Million | CN¥99.29 Million | CN¥188.38 Million | ▲ +25.8% |
| 2021 | 0.94x | CN¥197.24 Million | CN¥105.12 Million | CN¥209.37 Million | ▲ +18.7% |
| 2020 | 0.79x | CN¥87.96 Million | CN¥54.45 Million | CN¥110.81 Million | — |